Resultados de la búsqueda 1721-1730 of 15456 for crohns disease
... and trispecific antibodies and the factors that may determine disease progression and treatment response. Inotuzumab Ozogamicin in Treating Younger Patients ...
... Crohn, Poliposis adenomatosa familiar, Pólipos en el colon, Síndrome de intestino irritable, Cálculos biliares, Acalasia, Enfermedad por reflujo ...
The purpose of this study is to determine the safety and tolerability of personalized neoantigen peptide administered in combination with pembrolizumab to ...
The purpose of this study is to evaluate nab-paclitaxel as maintenance therapy after cisplatin-based chemotherapy and surgery in treating patients with ...
This study aims to identify candidate High Grade Serous Cancer (HGSC) early detection and chemotherapy treatment response biomarkers.
Rochester, Minn. The purpose of this study is to compare standard chemotherapy to therapy with CPX-351 and/or gilteritinib for patients with newly diagnosed ...
This study aims to understand the effects of physical activity compared with health education on memory, attention, and brain health in women with breast cancer ...
The purpose of this study is to evaluate the association between a baseline comprehensive geriatric assessment (cGA) and chemotherapy toxicity in the first 4 ...
The purpose of this study is to determine the safety and feasibility of complete outpatient blinatumomab administration for subjects with minimal residual ...
... and CLL patients, delay time to disease progression, assess the need for treatment, and assess infection rates. Pre-myeloid Cancer and Bone Marrow Failure ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?